4-(二甲基氨基)乙酰苯胺 | 7463-28-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 4-(二甲基氨基)乙酰苯胺
• 英文名称: N'-acetyl-N,N-dimethyl-1,4-phenylenediamine
• 英文别名: N-(4-(dimethylamino)phenyl)acetamide；4'-Dimethylaminoacetanilide；N-[4-(dimethylamino)phenyl]acetamide
• CAS: 7463-28-7
• 化学式: C₁₀H₁₄N₂O
• mdl: MFCD00157625
• 分子量: 178.234
• InChiKey: XZEJXEZIWLTFJR-UHFFFAOYSA-N

物化性质

• 熔点：
  132-133 °C
• 沸点：
  366.7±25.0 °C(Predicted)
• 密度：
  1?+-.0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  32.3
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 海关编码：
  2924299090

SDS

---

SECTION 1: Identification of the substance/mixture and of the company/undertaking
Product identifiers
Product name : 4'-(DIMETHYLAMINO)ACETANILIDE
REACH No. : A registration number is not available for this substance as the substance
or its uses are exempted from registration, the annual tonnage does not
require a registration or the registration is envisaged for a later
registration deadline.
CAS-No. : 7463-28-7
Relevant identified uses of the substance or mixture and uses advised against
Identified uses : Laboratory chemicals, Manufacture of substances

---

SECTION 2: Hazards identification
Classification of the substance or mixture
Not a hazardous substance or mixture according to Regulation (EC) No. 1272/2008.
This substance is not classified as dangerous according to Directive 67/548/EEC.
Label elements
This substance is not classified as dangerous according to Directive 67/548/EEC.
Other hazards - none

---

SECTION 3: Composition/information on ingredients
Substances
Formula : C10H14N2O
Molecular Weight : 178,24 g/mol
CAS-No. : 7463-28-7
No components need to be disclosed according to the applicable regulations.

---

SECTION 4: First aid measures
Description of first aid measures
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration.
In case of skin contact
Wash off with soap and plenty of water.
In case of eye contact
Flush eyes with water as a precaution.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water.
Most important symptoms and effects, both acute and delayed
The most important known symptoms and effects are described in the labelling (see section 2.2) and/or in
section 11
Indication of any immediate medical attention and special treatment needed
no data available

---

SECTION 5: Firefighting measures
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Carbon oxides, nitrogen oxides (NOx)
Advice for firefighters
Wear self contained breathing apparatus for fire fighting if necessary.
Further information
no data available

---

SECTION 6: Accidental release measures
Personal precautions, protective equipment and emergency procedures
Avoid dust formation. Avoid breathing vapours, mist or gas.
For personal protection see section 8.
Environmental precautions
Do not let product enter drains.
Methods and materials for containment and cleaning up
Sweep up and shovel. Keep in suitable, closed containers for disposal.
Reference to other sections
For disposal see section 13.

---

SECTION 7: Handling and storage
Precautions for safe handling
Provide appropriate exhaust ventilation at places where dust is formed.
For precautions see section 2.2.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
Specific end use(s)
Apart from the uses mentioned in section 1.2 no other specific uses are stipulated

---

SECTION 8: Exposure controls/personal protection
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
General industrial hygiene practice.
Personal protective equipment
Eye/face protection
Use equipment for eye protection tested and approved under appropriate government standards
such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
the standard EN 374 derived from it.
Body Protection
Choose body protection in relation to its type, to the concentration and amount of dangerous
substances, and to the specific work-place., The type of protective equipment must be selected
according to the concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
Respiratory protection is not required. Where protection from nuisance levels of dusts are desired,
use type N95 (US) or type P1 (EN 143) dust masks. Use respirators and components tested and
approved under appropriate government standards such as NIOSH (US) or CEN (EU).
Control of environmental exposure
Do not let product enter drains.

---

SECTION 9: Physical and chemical properties
Information on basic physical and chemical properties
a) Appearance Form: solid
b) Odour no data available
c) Odour Threshold no data available
d) pH no data available
e) Melting point/freezing no data available
point
f) Initial boiling point and no data available
boiling range
g) Flash point no data available
h) Evapouration rate no data available
i) Flammability (solid, gas) no data available
j) Upper/lower no data available
flammability or
explosive limits
k) Vapour pressure no data available
l) Vapour density no data available
m) Relative density no data available
n) Water solubility no data available
o) Partition coefficient: n- log Pow: 1,675
octanol/water
p) Auto-ignition no data available
temperature
q) Decomposition no data available
temperature
r) Viscosity no data available
s) Explosive properties no data available
t) Oxidizing properties no data available
Other safety information
no data available

---

SECTION 10: Stability and reactivity
Reactivity
no data available
Chemical stability
Stable under recommended storage conditions.
Possibility of hazardous reactions
no data available
Conditions to avoid
no data available
Incompatible materials
Strong oxidizing agents
Hazardous decomposition products
Other decomposition products - no data available
In the event of fire: see section 5

---

SECTION 11: Toxicological information
Information on toxicological effects
Acute toxicity
no data available
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitisation
no data available
Germ cell mutagenicity
no data available
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
no data available
Specific target organ toxicity - single exposure
no data available
Specific target organ toxicity - repeated exposure
no data available
Aspiration hazard
no data available
Additional Information
RTECS: Not available
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.

---

SECTION 12: Ecological information
Toxicity
no data available
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
Results of PBT and vPvB assessment
PBT/vPvB assessment not available as chemical safety assessment not required/not conducted
Other adverse effects
no data available

---

SECTION 13: Disposal considerations
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company.
Contaminated packaging
Dispose of as unused product.

---

SECTION 14: Transport information
UN number
ADR/RID: - IMDG: - IATA: -
UN proper shipping name
ADR/RID: Not dangerous goods
IMDG: Not dangerous goods
IATA: Not dangerous goods
Transport hazard class(es)
ADR/RID: - IMDG: - IATA: -
Packaging group
ADR/RID: - IMDG: - IATA: -
Environmental hazards
ADR/RID: no IMDG Marine pollutant: no IATA: no
Special precautions for user
no data available

---

---

SECTION 15 - REGULATORY INFORMATION
N/A

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  4-(二甲基氨基)乙酰苯胺 在 硫酸 、 硝酸 作用下， 生成 N¹,N¹-dimethyl-2,6-dinitro-p-phenylenediamine
  参考文献：
  名称：

  190.对-二甲基氨基乙酰苯胺的硝化作用

  摘要：

  DOI：

  10.1039/jr9340000873
• 作为产物：
  描述：

  N,N-二甲基对硝基苯胺 在 吡啶 、 palladium 10% on activated carbon 、 氢气 作用下， 以 乙醇 为溶剂， 反应 24.58h， 生成 4-(二甲基氨基)乙酰苯胺
  参考文献：
  名称：

  COMPOSITION FOR PREVENTING OR TREATING HAIR LOSS INCLUDING BENZENE DIAMINE DERIVATIVE

  摘要：

  提供了以下化合物I表示的化合物，或其溶剂络合物、立体异构体或药学上可接受的盐，以及用于预防或治疗脱发的组合物，该化合物包括作为活性成分的化合物：

  公开号：

  US20190092717A1

文献信息

• Selective Oxidative Coupling Reaction of Isocyanides Using Peroxide as Switchable Alkylating and Alkoxylating Reagent
  作者：Xinglu Zhang、Zhiqiang Liu、Yu Gao、Feng Li、Yaming Tian、Chunju Li、Xueshun Jia、Jian Li

  DOI：10.1002/adsc.201700953

  日期：2018.1.17

  A switchable oxidative coupling reaction of isocyanide and peroxide has been disclosed. In the presence of iron catalyst, the coupling reaction affords N‐arylacetamides in good yields. By simply replacing the iron with copper catalyst, another different coupling reaction takes place in which peroxide can serve as alkoxylating source. This protocol represents a new fundamental coupling of two basic

  已经公开了异氰酸酯和过氧化物的可切换的氧化偶联反应。在铁催化剂存在下，偶联反应可提供高收率的N-芳基乙酰胺。通过简单地用铜催化剂代替铁，就会发生另一种不同的偶联反应，其中过氧化物可以用作烷氧基化源。该协议代表了涉及C-C和C-O键形成过程的两种基本化学物质的新的基本耦合。自由基反应中异氰基的异常反应也已正式确立，而自由基反应在形式上起酰胺基合成子的作用。实验结果表明，在目前的偶联反应中，芳族异氰酸酯是特别相容的反应伙伴，而当使用脂族异氰酸酯时，没有观察到所需的产物。
• Nickel-catalyzed C–N bond reduction of aromatic and benzylic quaternary ammonium triflates
  作者：Yuan-Qiu-Qiang Yi、Wen-Cheng Yang、Dan-Dan Zhai、Xiang-Yu Zhang、Shuai-Qi Li、Bing-Tao Guan

  DOI：10.1039/c6cc04531f

  日期：——

  A nickel-catalyzed, efficient C-N bond reduction of aromatic and benzylic ammonium triflates has been developed using sodium isopropoxide as a reducing agent. The high efficiency, mild conditions, and nice compatibility...

  已经开发了使用异丙醇钠作为还原剂的镍催化的芳香族和苄基三氟甲磺酸铵的有效CN键还原方法。高效，温和的条件以及良好的兼容性...
• An Electrochemical Beckmann Rearrangement: Traditional Reaction via Modern Radical Mechanism
  作者：Li Tang、Zhi‐Lv Wang、Yan‐Hong He、Zhi Guan

  DOI：10.1002/cssc.202001553

  日期：2020.9.18

  electrochemical Beckmann rearrangement, i. e. the direct electrolysis of ketoximes to amides, is presented for the first time. Using a constant current as the driving force, the reaction can be easily carried out under neutral conditions at room temperature. Based on a series of mechanistic studies, a novel radical Beckmann rearrangement mechanism is proposed. This electrochemical Beckmann rearrangement does

  摘要：很少研究电合成作为将杂原子引入碳骨架的潜在手段。在此，电化学贝克曼重排，即。e。首次介绍了酮肟的直接电解成酰胺。使用恒定电流作为驱动力，可以在室温下在中性条件下容易地进行反应。在一系列机理研究的基础上，提出了一种新颖的自由基贝克曼重排机理。这种电化学贝克曼重排不遵循经典贝克曼重排的反迁移规则。
• An efficient catalytic method for the Beckmann rearrangement of ketoximes to amides and aldoximes to nitriles mediated by propylphosphonic anhydride (T3P®)
  作者：John Kallikat Augustine、Rajesha Kumar、Agnes Bombrun、Ashis Baran Mandal

  DOI：10.1016/j.tetlet.2010.12.090

  日期：2011.3

  An efficient method for the Beckmann rearrangement of ketoximes to amides mediated by a catalytic amount (15 mol %) of propylphosphonic anhydride (T3P®) is described. Aldoximes underwent second order Beckmann rearrangement to provide the corresponding nitriles in excellent yields on reacting with T3P (15 mol %) at room temperature. The main advantages of this environmentally friendly protocol include

  描述了一种由催化量（15摩尔％）的丙基膦酸酐介导的将酮肟的贝克曼重排成酰胺的有效方法。Aldoximes在室温下与T3P（15 mol％）反应后，进行了二阶Beckmann重排，从而以优异的产率提供了相应的腈。这种环境友好协议的主要优点包括程序简单，尤其是产品隔离容易。
• PYRROLIDINYL SULFONE RORGAMMA MODULATORS
  申请人：Bristol-Myers Squibb Company

  公开号：US20150191483A1

  公开（公告）日：2015-07-09

  Described are RORγ modulators of the formula (I), or stereoisomers, tautomers, pharmaceutically acceptable salts, solvates, or prodrugs thereof, wherein all substituents are defined herein. Also provided are pharmaceutical compositions comprising the same. Such compounds and compositions are useful in methods for modulating RORγ activity in a cell and methods for treating a subject suffering from a disease or disorder in which the subject would therapeutically benefit from modulation of RORγ activity, for example, autoimmune and/or inflammatory disorders.

  描述了公式（I）的RORγ调节剂，或其立体异构体、互变异构体、药物可接受的盐、溶剂化物或前药，其中所有取代基都在此定义。还提供了包含相同成分的药物组合物。这类化合物和组合物在调节细胞中RORγ活性的方法和治疗受疾病或紊乱困扰的主体中是有用的，例如，主体将从调节RORγ活性中获益的自免疫和/或炎症紊乱。